Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2000683	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Supplementary Application	2021-01-01	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	Certificate Issued	2021-09-22	view
JXSS2000035	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2020-09-30	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	Certificate Issued	2021-09-10	view
JXSS2000034	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2020-09-30	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	Certificate Issued	2021-09-10	view
JXSL2000177	度普利尤单抗注射液	dupilumab	Injection	Biological Products(2.2)	Import Drug Application	2020-10-14	Sanofi-aventis recherche & développement	Sanofi-Aventis Recherche & Developpement	In Review	2020-10-12	view
JXSL2000176	度普利尤单抗注射液	dupilumab	Injection	Biological Products(2.2)	Import Drug Application	2020-10-14	Sanofi-aventis recherche & développement	Sanofi-Aventis Recherche & Developpement	In Review	2020-10-12	view
JXSL2000190	度普利尤单抗注射液	dupilumab	Injection	Biological Products(2.2)	Import Drug Application	2020-10-27	Sanofi-aventis recherche & développement	Sanofi-Aventis Recherche & Developpement	In Review	2020-10-23	view
JXSL2000189	度普利尤单抗注射液	dupilumab	Injection	Biological Products(2.2)	Import Drug Application	2020-10-27	Sanofi-aventis recherche & développement	Sanofi-Aventis Recherche & Developpement	In Review	2020-10-23	view
JYSB2000388	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Supplementary Application	2020-08-21	Sanofi-aventis groupe	Sanofi-Aventis Groupe	Filed	2020-09-02	view
JXSL2400123	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2024-07-12					view
JXSL2200187	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2022-10-27					view
JYSB2300135	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2023-08-15					view
JYSB2400110	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-05-17		Sanofi Winthrop Industrie			view
JYSB2200175	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2022-09-09					view
JXSS2300007	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2023-01-12					view
JYSB2400077	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-04-04					view
JXSS2101006	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	Import Drug Application	2021-05-10					view
JXSL2101140	度普利尤单抗注射液	dupilumab	Injection	Biological Products(2.2)	Import Drug Application	2021-11-30					view
JYSB2300134	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2023-08-15					view
JYSB2400109	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-05-17		Sanofi Winthrop Industrie			view
JYSB2200081	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2022-05-07					view